Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Nutrition, doi:10.3945/jn.108.090704
Vol. 138, No. 11, 2070-2075, November 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holven, K. B.
Right arrow Articles by Halvorsen, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holven, K. B.
Right arrow Articles by Halvorsen, B.
© 2008 American Society for Nutrition J. Nutr. 138:2070-2075, November 2008


Biochemical, Molecular, and Genetic Mechanisms

The Antiatherogenic Function of HDL Is Impaired in Hyperhomocysteinemic Subjects1,2

Kirsten B. Holven3–5*, Pål Aukrust5,6, Kjetil Retterstøl4, Kari Otterdal5, Vigdis Bjerkeli5, Leiv Ose4, Marit S. Nenseter4,5 and Bente Halvorsen4

3 Institute for Basic Medical Sciences, Department of Nutrition, University of Oslo, Blindern, 0316 Oslo, Norway; and 4 The Lipid Clinic, 5 Research Institute for Internal Medicine, and 6 Section of Clinical Immunology and Infection Diseases, Medical Department, Rikshospitalet University Hospital, 0027 Oslo, Norway

* To whom correspondence should be addressed. E-mail: kirsten.holven{at}medisin.uio.no.

High plasma homocysteine concentrations have been associated with increased risk of cardiovascular disease, whereas plasma HDL concentration is inversely correlated to such disorders. We hypothesized that hyperhomocysteinemic subjects may have dysfunctional HDL. We therefore investigated the ability of serum from hyperhomocysteinemic male and female subjects (n = 10) and control subjects (n = 10) to induce cholesterol efflux and to inhibit release of inflammatory mediators from human umbilical vein endothelial cell. We found that serum from hyperhomocysteinemic subjects had impaired ability to induce cholesterol efflux from lipid-loaded macrophages compared with healthy controls. HDL from those with markedly raised homocysteine concentrations had a reduced antiinflammatory effect in tumor necrosis factor-{alpha}–activated endothelial cells with an attenuated suppressive effect on interleukin-6 growth-related oncogene-{alpha} release. Also, the activity of paraoxonase in serum, a multifunctional enzyme with antioxidative effects in relation to the function of HDL, was significantly reduced in hyperhomocysteinemic subjects, in particular those with markedly raised homocysteine concentration. Our findings suggest that hyperhomocysteinemic individuals have dysfunctional HDL particles with attenuated antiatherogenic activity and may represent a novel explanation for the increased risk of cardiovascular events in these individuals.








Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2008 by American Society for Nutrition